Discussion about this post

User's avatar
Tardigrade's avatar

I've mentioned this before, but any reader of Hyperlipid knows to always check the ingredients of the lab chow first.

Be especially cynical about lard. They started adulterating lard with cottonseed oil in the 1800s.

David Brown's avatar

"If you want to “reliably” induce obesity in humans or rats, feed them high amounts of linoleic acid."

Actually, according to Norwegian animal science researchers, high intake of linoleic acid will reliably displace arachidonic acid molecules from their positions in cell membranes. Excerpt: "Because AA competes with EPA and DHA as well as with LA, ALA and oleic acid for incorporation in membrane lipids at the same positions, all these fatty acids are important for controlling the AA concentration in membrane lipids, which in turn determines how much AA can be liberated and become available for prostaglandin biosynthesis following phospholipase activation. Thus, the best strategy for dampening prostanoid overproduction in disease situations would be to reduce the intake of AA, or reduce the intake of AA at the same time as the total intake of competing fatty acids (including oleic acid) is enhanced, rather than enhancing intakes of EPA and DHA only. Enhancement of membrane concentrations of EPA and DHA will not be as efficient as a similar decrease in the AA concentration for avoiding prostanoid overproduction." https://lipidworld.biomedcentral.com/articles/10.1186/1476-511X-9-37

Prostanoid overproduction does not affect feeding behavior. However, endocannabinoid overproduction does. Excerpt: "Experimental and clinical intervention studies suggest that omega-6 and omega-3 fatty acids have opposing physiological and metabolic properties and elicit divergent effects on body fat gain through mechanisms of adipogenesis, browning of adipose tissue, lipid homeostasis, systemic inflammation and an increase in the tone of the endocannabinoid system. Overweight and obese individuals have higher levels of the arachidonic acid (AA) derived endocannabinoid N-arachidonoylethanolamine (AEA) and 2-arachidonoylglycerol (2-AG) and an altered pattern of receptor expression. Since endocannabinoids are products of dietary fats, modification of the omega-6 and omega-3 fatty acid intake modulates the endocannabinoids, with eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) displacing AA from cell membranes, reducing AEA and 2-AG production, resulting in decrease in appetite and food intake leading to weight loss." https://www.ocl-journal.org/articles/ocl/full_html/2020/01/ocl190046s/ocl190046s.html

Eicosanoid and endocannabinoid production increases and decreases in parallel in response to proportionate changes in fatty omega-6s and 3s. Note, however, that fat-1 transgenic mice cannot be made fat by feeding them linoleic acid because they maintain the omega-3/6 balance in cell membranes no matter how much linoleic acid they are fed. (web search - fat-1 transgenic mice endocannabinoid system) They also cannot be made to overproduce inflammatory eicosanoids. (web search - fat-1 mice eicosanoids)

While high linoleic acid intake for humans may decrease heart attack risk early in life, high levels of circulating linoleic acid often cause varicose veins. https://yelling-stop.blogspot.com/2016/07/varicose-veins-and-linoleic-acid.html

Varicose veins are associated with a lower risk of CVD. Excerpt: "In the NAS population, men with VV were less likely to develop symptomatic CHD over the 35+ years of follow-up than were subjects without VV. https://www.sciencedirect.com/science/article/abs/pii/S0890509606613915

Note, however, that varicose veins are associated with an elevated risk of congestive heart failure later on in life. https://pubmed.ncbi.nlm.nih.gov/20087281/

So, increasing linoleic acid intake to prevent CVD is like jumping from a frying pan into a slow cooker.

No posts

Ready for more?